Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy

Advanced Drug Delivery Reviews

Volumn 30, Issue 1-3, 1998, Pages 219-227

  Hung, Mien Chie ^a   Yujiao Chang, Joe ^a   Xing, Xiangming ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer; Cationic liposome; E1A; Gene transfer; Large T; Ovarian cancer

Indexed keywords

ANTIGENS; BIOASSAY; CELLS; DISEASES; DRUG DOSAGE; GENES; GENETIC ENGINEERING; IMMUNOLOGY; ONCOLOGY; TOXICITY; VIRUSES;

BREAST CANCER; CATIONIC LIPOSOME; GENE THERAPY; OVARIAN CANCER;

DRUG THERAPY;

3BETA [N (N',N' DIMETHYLAMINO)ETHANECARBAMOYL]CHOLESTEROL; DNA; LIPOSOME; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; BREAST CANCER; CANCER; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE TARGETING; GENE TRANSFER; HUMAN; NONHUMAN; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; SURVIVAL;

EID: 0032473493     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00118-X     Document Type: Review

References (68)

1. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
2. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M., Felgner P.L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269:1994;2550-2561.
3. Zhou X., Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim. Biophys. Acta. 1189:1994;195-203.
4. Behr J.P., Demeneix B., Leoffler J.P., Perez-Mutul J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. USA. 86:1989;6982-6986.
5. Pinnaduwage P., Schmitt L., Hunag L. Use of a quaternary ammonium detergent in liposome mediated transfection of mouse L-cells. Biochim. Biophys. Acta. 985:1989;33-37.
6. Jiao S., Williams P., Berg R.K., Hodgeman B.A., Liu L., Repetto G., Wolff J.A. Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene Ther. 3:1992;21-33.
7. Gao X., Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:1991;280-285.
8. Nabel G., Nabel E.G., Yang Z., Fox B.A., Plautz G.E., Gao X., Huang L., Shu S., Gordon D., Chang A.E. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biological activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA. 90:1993;11307-11311.
9. Caplen N.J., Alton E.W.F.W., Meddleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K., Hodson M.E., Coutelle C., Huang L., Porteous D.J., Williamson R., Geddes D.M. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1:1995;39-46.
10. Coussens L., Yang-Feng T.L., Liao Y.C., Chen E., Gray A., McGrath J., Seeburg P.H., Libermann T.A., Schlessinger J., Francke U., Levinson U.F.A., Ullrich A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogenes. Science. 230:1985;1132-1139.
11. Bargmann C.I., Hung M.C., Weinber R.A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature. 319:1986;226-230.
12. Yamamoto T., Ikawa S., Akiyama K.S., Nomura N., Miyajima N., Saito T., Toyoshima K. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature. 319:1986;230-232.
13. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human ovarian cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 23:1987;177-182.
14. Borg A., Tandon A.K., Sigurdfsson H., Clark G.M., Ferno M., Fuqua S.A.W., Killander D., McGuire W.L. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res. 50:1990;4332-4337.
15. Paterson M.C., Dietrich K.D., Danyluk J., Paterson A.H.G., Lees A.W., Jamil N., Hanson J., Jenkins H., Krause B.E., McBlain W.A., Slamon D.J., Fourney R.M. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 51:1991;556-567.
16. Press M.F., Pike M.C., Chazin V.R., Hung G., Udove J.A., Markowicz J.D., Godolphin W., Sliwkowski M., Akita R., Paterson M.C., Slamon D. HER-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res. 53:1993;4960-4970.
17. Berchuck A., Kamel A., Whitake R., Kerns B., Olt G., Kinney R., Soper J.T., Dodge R., Clarke-Pearson D.L., Marks P., McKenzie S., Yin S., Bast R.C. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50:1990;4087-4091.
18. Muller W.J., Sun E., Pattengale P.K., Wallace R., Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 54:1988;105-115.
19. Bouchard L., Lamarre L., Tremblay P.J., Jolicoeur P. Stochastic appearance of mammary tumors in transgenic mice carrying MMTV/c-neu oncogene. Cell. 57:1989;931-936.
20. Guy C.T., Webster M.A., Schaller L., Parsons T.J., Cardiff R.D., Muller W.J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA. 89:1992;10578-10582.
21. Yu D., Hung M.C. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene. 6:1991;1991-1996.
22. Yu D., Wang S.S., Dulski K.M., Tsai C.M., Nicolson G.L., Hung M.C. c-erbB-2/neu Overexpression enhances metastatic potential of human lung carcinoma cells by induction of metastatic-associated properties. Cancer Res. 54:1994;3260-3266.
23. Tsai C.M., Chang K.T., Perng R.P., Mitsudomi T., Chen M.H., Gazdar A.F. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu transfected human lung cancer cells. J. Natl. Cancer Inst. 85:1993;897-901.
24. Tsai C.M., Yu D., Chang K.T., Wu L.H., Perng R.P., Ibrahim N.K., Hung M.C. Enhanced chemoresistance by elevation of the levels of p185-neu in the HER-2/neu transfected human lung cancer cells. J. Natl. Cancer Inst. 87:1995;682-684.
25. Baselga J., Tripathy D., Mendelsohn J., Baughman S., Benz C.C., Dantis L., Sklarin N.T., Seidman A.D., Hudis C.A., Moore J., Rosen P.P., Twaddell T., Henderson I.C., Norton L. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14:1996;737-744.
26. Yu D., Scorsone K., Hung M.C. Adenovirus type 5 E1A gene products act as transformation suppressor of the neu oncogene. Mol. Cell. Biol. 11:1991;1745-1750.
27. Yu D., Suen T.C., Yan D.H., Chang L.S., Hung M.C. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc. Natl. Acad. Sci. USA. 87:1990;4499-4503.
28. Yan D.H., Chang L.S., Hung M.C. Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products. Oncogene. 6:1991;343-345.
29. Yu D., Hamada J.I., Zhang H., Nicolson G.L., Hung M.C. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 gene products. Oncogene. 7:1992;2263-2270.
30. Yu D., Shi D., Scanlon M., Hung M.C. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A. Cancer Res. 53:1993;5784-5790.
31. Ruley H.E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 304:1993;602-606.
32. Byrd P.J., Grand R.J.A., Gallimore P.H. Differential transformation of primary human embryo retinal cells by adenovirus E1A regions and combination of E1A (+) ras. Oncogene. 2:1988;477-484.
33. Houweling A., van den Elsen P.J., van der Eb A.J. Partial transformation of primary rat cells by the 4.5% fragment of adenovirus 5 DNA. Virology. 105:1980;537-550.
34. Davenport E.A., Drobes B.L., Menke S.L., Tushar T.B., Taparowsky E.J. Cooperation of oncogenes in the multistep transformation of established fibroblasts in culture. Anticancer Res. 8:1988;957-970.
35. Quinlan M.P. Enhanced proliferation, growth factor induction and immortalization by adenovirus E1A 12S in the absence of E1B. Oncogene. 9:1994;1639-1647.
36. Yu D., Wolf J.K., Scanlon M., Price J.E., Hung M.C. Enhanced c-erbB-2/neu expression in human ovarian carcinoma cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res. 53:1993;891-898.
37. Zhang Y.J., Yu D.H., Xia W.Y., Hung M.C. HER-2/neu-targeting cancer gene therapy with adenovirus mediated E1A gene delivery in an animal model. Oncogene. 10:1995;1947-1954.
38. Yu D., Matin A., Xia W., Sorgi F., Huang L., Hung M.C. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. Oncogene. 11:1995;1383-1388.
39. J.Y. Chang, W. Xia, Y. Shao, F. Sorgi, G. Hortobagyi, L. Huang, M.C. Hung, E1A tumor suppressing activity in HER-2/neu-overexpressing breast cancer, Oncogene (1996) in press.
40. Chang J.Y., Xia W., Shao Y., Hung M.C. Inhibition of intratracheal tumor development by systemic delivery of E1A. Oncogene. 13:1996;1405-1412.
41. Frisch S.M., Dolter K.E. Adenovirus E1a-mediated tumor supression by c-erbB-2/neu-independent mechanism. Cancer Res. 55:1995;5551-5555.
42. Garbisa S., Pozzatti R., Muschel R.J., Umberto S., Ballin M., Goldfarb R.H., Khoury G., Liotta L.A. Secretion of type IV collagenolytic proteinase and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1A. Cancer Res. 47:1987;1523-1587.
43. Frisch S.M. Antioncogenic effect of adenovirus E1A in human tumor cells. Proc. Natl. Acad. Sci. USA. 88:1991;9077-9081.
44. Frisch S.M., Reich R., Collier I.E., Genrich T., Martin G., Golberg G.I. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene. 5:1990;75-83.
45. Pozzatti R., McCormick M., Thompson M.A., Khoury G. The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol. Cell. Biol. 8:1988;2984-2988.
46. Steeg P.S., Bevilacqua G., Pozzatti R., Liotta L.A., Sobel M.E. Altered expression of NM23, a gene associated with low tumor metastasis potential, during adenovirus 2 E1a inhibition of experimental metastasis. Cancer Res. 48:1988;6550-6554.
47. Boyd J.M., Subramanian T., Schaeper U., Regina M.L., Bayley S., Chinnadurai G. C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenicity and metastasis. EMBO J. 12:1993;469-478.
48. Schaeper U., Boyd J.M., Verma S., Uhlmann E., Subramanian T., Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. USA. 92:1995;10467-10471.
49. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:1994;619-626.
50. Chinnadurai G. E1A as a tumor suppressor gene. Oncogene. 7:1992;1255-1258.
51. Matin A., Hung M.C. Negative regulation of the neu promoter by the SV40 large T antigen. Cell Growth Differ. 4:1993;1051-1056.
52. Baker T., Piver M.S. Etiology, biology and epidemiology of ovarian cancer. Semin. Surg. Oncol. 10:1994;242-248.
53. Creasman W., DiSaia P. Screening in ovarian cancer. Am. J. Obstet. Gynecol. 165:1991;7-10.
54. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer Stastistics, 1996. CA Cancer J. Clin. 46:1996;5-27.
55. Xing X., Matin A., Yu D., Xia W., Sorgi F., Huang L., Hung M.C. Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer. Cancer Gene Ther. 3:1996;168-174.
56. Freirech E.J., Gehan E.A., Rall D.P., Schmidt L.H., Skipper H.E. Quantitative comparison of toxicity of anticancer agents on mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50:1966;219-244.
57. Stewart M.J., Pautz G.E., Buono L.D., Yang Z.Y., Xu L., Gao X., Huang L., Nabel E.G., Nabel G.J. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum. Gene Ther. 3:1992;267-275.
58. Nabel E.G., Gordon D., Yang Z.Y., Xu L., San H., Plautz G.E., Wu B.Y., Gao X., Huang L., Nabel G.J. Gene transfer in vivo with DNA-liposome complexes: lack of antuoimmunity and gonadal localization. Hum. Gene Ther. 3:1992;649-656.
59. Lew D., Parker S.E., Latimer T., Abai A.M., Kuwahara-Rundell A., Doh S.G., Yang Z.Y., Laface D., Gromkowski S.H., Nabel G.J., Manthorpe M., Norman J. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6:1995;553-564.
60. Parker S.E., Vahlsing H.L., Serfilippi L.M., Franklin C.L., Doh S.G., Gromkowski S.H., Lew D., Manthorpe D., Norman J. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates. Hum. Gene Ther. 6:1995;575-590.
61. Simon R.H., Engelhardt J.F., Yang Y., Zepeda M., Weber-pendleton S., Grossman M., Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Ther. 4:1993;771-780.
62. Knowles M.R., Hohnker K.W., Zhou Z., Olsen J.C., Noah T.L. A controled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl. J. Med. 333:1995;823-831.
63. Nabel E.G., Yang Z., Muller D., Chang A.E., Gao X., Huang L., Cho K., Nabel G.J. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. Hum. Gene Ther. 5:1994;1089-1094.
64. Gao X., Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry. 35:1996;1027-1036.
65. Curiel D.T., Agarwal S., Wagner E., Cotten M. Adenovirus enhancement of tansferrin-polylysine adenovirus-mediated gene delivery. Proc. Natl. Acad. Sci. USA. 88:1991;8850-8854.
66. Cristiano R.J., Smith L.C., Woo S.L. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl. Acad. Sci. USA. 90:1993;2122-2126.
67. Park J.W., Hong K., Carter P., Asgari H., Guo L.Y., Keller G.A., Wirth C., Shalaby R., Kotts C., Wood W.I., Papahadjopoulos D., Benz C.C. Development of anti-p185 HER-2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA. 92:1995;1327-1331.
68. Lee R.J., Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271:1996;8481-8487.